ReviewExperimental hematology & oncology2022

Bruton tyrosine kinase inhibitors in B-cell lymphoma: beyond the antitumour effect.

Haoran Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.